Artificial intelligence, robots and blockchain deliver next-generation healthcare, today

Published at: Feb. 16, 2023

Pharmacy visitors expect quick service - to have their prescription filled quickly, or over-the-counter remedy purchased in just a few minutes. In this rapid interaction, little thought goes to the journey of that medicine from a microscope slide to mass production. 

In reality, the drug discovery process is incredibly time and research-intensive. Despite significant advancements in manufacturing and discovery, the average time to bring a drug from the initial stage to market is 10-15 years and costs millions of dollars.

Emerging technologies are transforming healthcare and drug discovery. Artificial intelligence, for example, is doing the “dirty work” of drug discovery by running simulations of drug efficacy instead of timely trial-and-error testing. Blockchain secures healthcare records and connects patients with new clinical trials. AR and VR tools help patients overcome phobias and fear during medical treatments. AI will help future drugs reach the market (some believe this can be cut down to just five years!), delivering life-changing results for illness sufferers worldwide. 

The biggest obstacle to achieving these changes and this tech going mainstream? Us, the patients. We all need to understand the power and promise of these technologies and push for them - or, at least, not fear them.

Supporting AI and blockchain in the healthcare sector

There’s a popular image going around on social media that reads, “AI will not replace jobs. People using AI will replace people’s jobs.” With its easy-to-use interface, ChatGPT is showing people how AI might look in our day-to-day lives. One thing you probably can’t ask the chatbot for? A new compound for a pill to cure deadly diseases. And that’s good because AI applications in medicine should be managed by professionals.

These professionals have known about the power of AI for years, working behind the scenes to develop real use cases. Insilico Medicine brought its knowledge into the spotlight when it announced its “sixth-generation” robotics laboratory in early January. Sixth-gen status means the lab is fully automated, with robotics and AI algorithms conducting ​​target discovery, compound screening, precision medicine development, and translational research. 

You may be wondering, what does fully automated mean for the scientists previously doing these jobs at Insilico? It’s just as the image I mentioned earlier suggests: by integrating technology and speeding up processes, researchers can focus on the “human” side of their work. They are free to focus on critical tasks like clinical trial development and side effect studies because they know technology handles the rest. Ask anyone in biotech: AI is now foundational to drug discovery,

AI-native Insilico Medicine is no stranger to this emerging tech. In 2019, the company partnered with clinical trial startup Longenesis and a South Korean medical center to create a blockchain-powered health data management tool. They designed the platform to protect patient information and comply with guidelines like the Health Insurance Portability and Accountability Act (HIPAA) and General Data Protection Regulation (GDPR). Patients may have known these guidelines existed but did not understand how to manage their data effectively. In contrast, blockchain technology brings these regulations to life, empowering patients to manage their privacy and monitor their data. That’s where the future of health tech lies, at patients’ fingertips. 

Calling all patients: Healthcare transformation is in your hands

One of the lasting takeaways from COVID-19 was how crisis catalyzes breakthroughs. When faced with a common threat, scientific collaboration was not just a feel-good initiative–it was a dire mandate. The results were astonishing and historic. Scientists from around the globe used existing research to produce a vaccine in just a year, remarkably faster than the typical 5-10 year vaccine development timeline. 

The breakthroughs continued after vaccine distribution. Scientists today are applying the mRNA technology used in COVID jabs to develop new vaccines. Their targets? Devastating and hard-to-treat diseases like colorectal cancers and Lyme. AI and other technologies will help accelerate this process and propel this innovation forward, supporting researchers to change (and save) lives. 

2020 also taught us that public health matters for everyone. The onslaught of COVID brought concepts like mRNA and cytokine storms into daily life as people tuned into news reports and scientific publications to stay informed. This trend needs to continue. We have a responsibility to stay educated about healthcare breakthroughs as they impact us immeasurably. I cannot stress this enough: to take advantage of the future of medicine, you need to keep an open mind. 

I have complete faith in the crypto community to take this to heart. We’ve seen the technology behind Bitcoin redefine the digital art world with NFTs. We’ve witnessed DAOs revamp how teams manage projects. We’ve raised money for the world’s most important causes using decentralized tech. Now, it’s time for us to explore the next frontier of health. Scientists are building a future where AI-discovered medicines, virtual appointments and psychedelic mental health treatments will be the norm. Are you ready to be part of it?

The scientific community came together before to deliver life-changing research, and it is time for us to rally again in support of a more digital future of health. I encourage you to donate to research organizations, get smart on health tech and explore what artificial intelligence and personalized medicine could mean for your personal care. Resources are available across the web, and joining communities like nonprofits, DAOs and Discord chats is a great place to get started. In conclusion: technology can and will transform our health. It’s up to us to bring this transformation to life.

Tags
Related Posts
Tech Startup Nebula Genomics Launches Blockchain-Based DNA Sequencing
Tech startup Nebula Genomics is launching DNA sequencing using blockchain — eliminating the need for customers to reveal personal information. According to a blog post published on Sept. 19, Nebula has rolled out anonymous genetic testing, enabling clients to purchase whole genome sequencing and provide saliva samples without the need to share personal data such as their name, address or credit card number. Eliminating dependence on data de-identification To achieve this, Nebula developed and implemented a blockchain-based product that enables transparent and controllable data sharing, and offers an option to conduct pseudo-anonymous payments using cryptocurrencies. For those customers who do …
Adoption / Sept. 20, 2019
Blockchain Genomics Firm, Merck’s EMD Serono Sign Anonymized Data Sharing Agreement
Blockchain firm Nebula Genomics has announced a collaboration with EMD Serono, the North American biopharmaceutical business of Merck KGaA — the world’s oldest operating pharmaceutical firm. The news was announced in a press release shared with Cointelegraph on June 11. As previously reported, Nebula is a blockchain-powered platform for genome-sequencing data, co-founded in 2017 by renowned geneticist Professor George Church and his Harvard colleagues Dennis Grishin and Kamal Obbad. The platform leverages blockchain technology in a bid to incentivize genomic data generation and sharing, and to lower the costs of genome-sequencing while preserving privacy and individuals’ control over their unique …
Adoption / June 11, 2019
Bitfury’s New Partnership to Build Blockchain-Based Medical Imaging Platform
Blockchain tech company Bitfury is partnering with radiology blockchain marketplace Medical Diagnostic Web (MDW) to create a blockchain-based medical imaging ecosystem. The partnership was announced by the Bitfury Group in a blog post on Feb. 11. Established in 2011, the Bitfury Group operates as a software manufacturer and provider of security and infrastructure for the Bitcoin (BTC) blockchain. The company raised $500 million in revenue in 2018. MDW is a radiology blockchain platform that allows radiologists to contact with imaging facilities and share patient data and medical images. Within the new collaboration, Bitfury, MDW and blockchain-powered life data marketplace Longenesis …
Adoption / Feb. 11, 2019
Taiwan Hospital Launches Blockchain Platform to Improve Medical Record-Keeping
The Taipei Medical University Hospital has rolled out a blockchain-powered platform to improve medical record-keeping, Taipei Times reported August 31. The so called “Healthcare Blockchain Platform” was reportedly developed in order to support the government’s Hierarchical Medical System policy, improve patient referral services, and integrate individual healthcare networks to enable people to access their medical records in an easier way. To make a request for their records, patients can log in to a password-protected mobile app. The project involved over 100 clinics, which deploy blockchain technology to address major issues in healthcare, such as data transfer between medical establishments and …
Adoption / Sept. 1, 2018
Genomics company explores NFTs in hopes of advancing precision medicine
It’s predicted that nonfungible tokens (NFTs) will have a vast impact on society. Given this, it shouldn’t come as a surprise that the trillion-dollar healthcare sector has begun to explore NFTs tokens to advance medicine. It’s also important to point out that blockchain technology can play an increasingly important role within the healthcare sector. This was recently highlighted in a report from the European Union Blockchain Observatory, which specifically documents how blockchain applications can solve challenges facing the healthcare industry. For example, the paper notes that patient engagement and transparency of how data is stored, along with the effective distribution …
Decentralization / May 23, 2022